| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 124.27B | 136.82B | 122.68B | 150.74B | 161.88B | 140.32B |
| Gross Profit | 23.30B | 24.45B | 23.73B | 31.86B | 36.93B | 31.25B |
| EBITDA | 9.27B | 10.66B | 10.03B | -10.12B | 19.27B | -2.89B |
| Net Income | -588.00M | 2.37B | 37.00M | -21.29B | 2.27B | -12.12B |
Balance Sheet | ||||||
| Total Assets | 162.46B | 165.99B | 162.70B | 172.92B | 162.74B | 156.14B |
| Cash, Cash Equivalents and Short-Term Investments | 24.13B | 21.29B | 23.87B | 45.30B | 26.14B | 24.76B |
| Total Debt | 75.92B | 70.51B | 78.24B | 89.39B | 70.21B | 58.41B |
| Total Liabilities | 108.61B | 102.85B | 106.03B | 119.31B | 112.06B | 111.42B |
| Stockholders Equity | 53.30B | 62.48B | 56.12B | 53.10B | 50.26B | 44.42B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.25B | -9.82B | -22.42B | -11.69B | -294.00M |
| Operating Cash Flow | 0.00 | 7.62B | -493.00M | -12.96B | -4.86B | 5.11B |
| Investing Cash Flow | 0.00 | -5.29B | -9.75B | -4.82B | -6.83B | -5.21B |
| Financing Cash Flow | 0.00 | -6.23B | -11.93B | 35.42B | 12.05B | -218.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥15.75T | 75.03 | 8.95% | 1.88% | 5.02% | 2.02% | |
66 Neutral | ¥433.12B | 15.21 | 11.96% | 3.04% | 2.93% | -26.76% | |
64 Neutral | ¥7.20T | 39.87 | ― | 1.41% | 13.61% | 17.01% | |
62 Neutral | ¥1.63T | 125.20 | ― | 2.57% | 4.07% | 533.21% | |
62 Neutral | ¥239.95B | 40.12 | ― | 2.18% | -3.43% | 9.82% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
51 Neutral | ¥120.25B | 49.29 | 2.26% | ― | 11.52% | 5786.05% |